This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

United Therapeutics Corporation (UTHR): Today's Featured Health Care Loser

United Therapeutics Corporation ( UTHR) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole was unchanged today. By the end of trading, United Therapeutics Corporation fell 53 cents (-1.3%) to $42.02 on light volume. Throughout the day, 971,088 shares of United Therapeutics Corporation exchanged hands as compared to its average daily volume of 1.8 million shares. The stock ranged in price between $41.32-$43.60 after having opened the day at $42.77 as compared to the previous trading day's close of $42.55. Other company's within the Health Care sector that declined today were: China Sky One Medical Inc ( CSKI), down 15.7%, Medgenics Inc ( MDGN), down 15.7%, Vermillion Inc ( VRML), down 15.2%, and Pressure BioSciences Inc ( PBIO), down 14.3%.

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and Internationally. United Therapeutics Corporation has a market cap of $2.52 billion and is part of the drugs industry. The company has a P/E ratio of 14.7, above the average drugs industry P/E ratio of 14.5 and below the S&P 500 P/E ratio of 17.7. Shares are down 32.7% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates United as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow.

On the positive front, Arrowhead Research Corporation ( ARWR), up 40.2%, Cardium Therapeutics Inc ( CXM), up 12.8%, Bovie Medical Corporation ( BVX), up 11.3%, and Misonix Inc ( MSON), up 8.8%, were all gainers within the health care sector with Merck & Co Inc ( MRK) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs